New study finds triple-negative breast cancer tumors with an …
WEBApr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
Estrogen a more powerful breast cancer culprit than we realized
WEBMay 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
WEBJun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
Recommendations to begin breast cancer screening at age 40
WEBJun 5, 2024 · All women should begin breast cancer screening at the age of 40, says the U.S. Preventive Services Task Force. In a new recommendation, the task force advises cisgender women and all other people assigned female at birth aged 40 to 74 years get screened every other year.
What's New in Breast Cancer - Susan G. Komen®
WEBLearn about new breast cancer treatment breakthroughs and recent developments in research that are fueling new ways to assess risk, prevent, detect and diagnose breast cancer.
In Reversal, Expert Panel Recommends Breast Cancer Screening at …
WEBApr 30, 2024 · Citing rising breast cancer rates in young women, an expert panel on Tuesday recommended starting regular mammography screening at age 40, reversing longstanding and controversial guidance that...
Pembrolizumab for Advanced Triple-Negative Breast Cancer
WEBAug 9, 2022 · In the KEYNOTE-355 trial, 847 patients with advanced (unresectable, locally advanced, or metastatic) triple-negative breast cancer were randomly assigned to receive chemotherapy plus placebo or chemotherapy plus pembrolizumab.
Experimental immunotherapy targets metastatic breast cancer
WEBFeb 1, 2022 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).
New Treatments Emerge for Metastatic HER2+ Breast Cancer
WEBJan 8, 2020 · Two new treatment options are emerging for women with metastatic breast cancer, following positive results from clinical trials. The trials tested the drugs tucatinib and trastuzumab deruxtecan ( Enhertu) in women who had been previously treated for metastatic breast cancer that overproduces the HER2 protein, known as …
Breast cancer metastasis on/off switch revealed - Stanford News
WEBDecember 20th, 2023 | 5 min read Science & Engineering. Researchers uncover on/off switch for breast cancer metastasis. New research from Stanford and the Arc Institute could lead to a new and more effective immunotherapy and help clinicians better predict patient response to existing medicines.
Skip to content